Electra Therapeutics, Inc.
- Ticker
- ETRA
- CIK
- 2088082
- Industry
- Biological Products, (No Diagnostic Substances)
Financials 1
News 2
Ownership 22
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
- 4 Statement of changes in beneficial ownership of securities
Prospectus 7
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- 424B4 Prospectus filed pursuant to Rule 424(b)(4)
- S-1MEF A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
- S-1/A General form of registration statement for all companies including face-amount certificate companies
- S-1 General form of registration statement for all companies including face-amount certificate companies
- DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
- DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Other 9
- SCHEDULE 13G
- SCHEDULE 13G
- SCHEDULE 13G
- SCHEDULE 13G
- SCHEDULE 13D
- CERT Certification by an exchange approving securities for listing
- 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
- EFFECT Notice of Effectiveness
- D Exempt (Private) Offering